The DOI matches its Crossref record.
Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone
Open accessAbstract
The cysteine protease CPP32 has been expressed in a soluble form in Escherichia coli and purified to >95% purity. The three-dimensional structure of human CPP32 in complex with the irreversible tetrapeptide inhibitor acetyl-Asp-Val-Ala-Asp fluoromethyl ketone was determined by x-ray crystallography at a resolution of 2.3 A. The asymmetric unit contains a (p17/p12)2 tetramer, in agreement with the tetrameric structure of the protein in solution as determined by dynamic light scattering and size exclusion chromatography. The overall topology of CPP32 is very similar to that of interleukin-1beta-converting enzyme (ICE); however, differences exist at the N terminus of the p17 subunit, where the first helix found in ICE is missing in CPP32. A deletion/insertion pattern is responsible for the striking differences observed in the loops around the active site. In addition, the P1 carbonyl of the ketone inhibitor is pointing into the oxyanion hole and forms a hydrogen bond with the peptidic nitrogen of Gly-122, resulting in a different state compared with the tetrahedral intermediate observed in the structure of ICE and CPP32 in complex with an aldehyde inhibitor. The topology of the interface formed by the two p17/p12 heterodimers of CPP32 is different from that of ICE. This results in different orientations of CPP32 heterodimers compared with ICE heterodimers, which could affect substrate recognition. This structural information will be invaluable for the design of small synthetic inhibitors of CPP32 as well as for the design of CPP32 mutants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,760
Molecular mechanisms of caspase regulation during apoptosis
Riedl, S. J., & Shi, Y. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1496 · Cited by 1,899
Mechanisms of Caspase Activation and Inhibition during Apoptosis
Shi, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00482-3 · Cited by 1,833
Caspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases
Wolf, B. B., & Green, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20049 · Cited by 942
Protease Inhibitors: Current Status and Future Prospects
Leung, D., Abbenante, G., & Fairlie, D. P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990412m · Cited by 883
The protein structures that shape caspase activity, specificity, activation and inhibition
FUENTES-PRIOR, P., & SALVESEN, G. S. (2004) · Biochemical Journal · doi:10.1042/bj20041142 · Cited by 880
The machinery of programmed cell death
Zimmermann, K. C., Bonzon, C., & Green, D. R. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00159-0 · Cited by 833
Structural Basis for the Inhibition of Caspase-3 by XIAP
Riedl, S. J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C., Fesik, S. W., Liddington, R. C., & Salvesen, G. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00274-4 · Cited by 792
Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease
Stevens, J. F., & Maier, C. S. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700412 · Cited by 755
Mitochondrial Release of Caspase-2 and -9 during the Apoptotic Process
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Brenner, C., Larochette, N., Prévost, M.-C., Alzari, P. M., & Kroemer, G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.381 · Cited by 710
Marzo, I., Brenner, C., Zamzami, N., Susin, S. A., Beutner, G., Brdiczka, D., Rémy, R., Xie, Z.-H., Reed, J. C., & Kroemer, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1261 · Cited by 684
An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7
Shin, S., Sung, B.-J., Cho, Y.-S., Kim, H.-J., Ha, N.-C., Hwang, J.-I., Chung, C.-W., Jung, Y.-K., & Oh, B.-H. (2001) · Biochemistry · doi:10.1021/bi001603q · Cited by 674
Caspases: pharmacological manipulation of cell death
Lavrik, I. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26252 · Cited by 644
A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases
Takahashi, R., Deveraux, Q., Tamm, I., Welsh, K., Assa-Munt, N., Salvesen, G. S., & Reed, J. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.7787 · Cited by 608
Structural Basis of Caspase-7 Inhibition by XIAP
Chai, J., Shiozaki, E., Srinivasula, S. M., Wu, Q., Dataa, P., Alnemri, E. S., & Shi, Y. (2001) · Cell · doi:10.1016/s0092-8674(01)00272-0 · Cited by 581
The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex
Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W., Briand, C., & Grütter, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206882200 · Cited by 482
Self-citationCaspases: key players in programmed cell death
Grütter, M. G. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00146-9 · Cited by 482
Self-citationStructural Basis of Caspase Inhibition by XIAP
Huang, Y., Park, Y. C., Rich, R. L., Segal, D., Myszka, D. G., & Wu, H. (2001) · Cell · doi:10.1016/s0092-8674(01)00273-2 · Cited by 467
Dimer formation drives the activation of the cell death protease caspase 9
Renatus, M., Stennicke, H. R., Scott, F. L., Liddington, R. C., & Salvesen, G. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231465798 · Cited by 449
Caspase and calpain substrates: Roles in synaptic plasticity and cell death
Chan, S. L., & Mattson, M. P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991001)58:1<167::aid-jnr16>3.0.co;2-k · Cited by 432
CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
Krammer, P. H. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60402-2 · Cited by 394
The Role of Caspases in Development, Immunity, and Apoptotic Signal Transduction
Los, M., Wesselborg, S., & Schulze-Osthoff, K. (1999) · Immunity · doi:10.1016/s1074-7613(00)80062-x · Cited by 391
Stennicke, H. R., & Salvesen, G. S. (1998) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(98)00133-2 · Cited by 372
Chowdhury, I., Tharakan, B., & Bhat, G. K. (2008) · Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2008.05.010 · Cited by 368
Caspases – controlling intracellular signals by protease zymogen activation
Stennicke, H. R., & Salvesen, G. S. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00281-2 · Cited by 330
Apoptosis-regulating proteins as targets for drug discovery
Reed, J. C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02026-3 · Cited by 328
Stennicke, H. R., Renatus, M., Meldal, M., & Salvesen, G. S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500563 · Cited by 320
CASH, a Novel Caspase Homologue with Death Effector Domains
Goltsev, Y. V., Kovalenko, A. V., Arnold, E., Varfolomeev, E. E., Brodianskii, V. M., & Wallach, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19641 · Cited by 318
Insights into Programmed Cell Death through Structural Biology
Fesik, S. W. (2000) · Cell · doi:10.1016/s0092-8674(00)00119-7 · Cited by 312
Caspases: Keys in the Ignition of Cell Death
Denault, J.-B., & Salvesen, G. S. (2002) · Chemical Reviews · doi:10.1021/cr010183n · Cited by 309
Endogenous Reactive Intermediates as Modulators of Cell Signaling and Cell Death
West, J. D., & Marnett, L. J. (2006) · Chemical Research in Toxicology · doi:10.1021/tx050321u · Cited by 295
Caspases: opening the boxes and interpreting the arrows
Salvesen, G. S. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400963 · Cited by 280
Cleavage and Shedding of E-cadherin after Induction of Apoptosis
Steinhusen, U., Weiske, J., Badock, V., Tauber, R., Bommert, K., & Huber, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006102200 · Cited by 278
Yang, L.-W., & Bahar, I. (2005) · Structure · doi:10.1016/j.str.2005.03.015 · Cited by 273
Weng, C., Li, Y., Xu, D., Shi, Y., & Tang, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412819200 · Cited by 254
ANNAND, R. R., DAHLEN, J. R., SPRECHER, C. A., DREU, P. D., FOSTER, D. C., MANKOVICH, J. A., TALANIAN, R. V., KISIEL, W., & GIEGEL, D. A. (1999) · Biochemical Journal · doi:10.1042/bj3420655 · Cited by 106
Yun, C. Y., Liu, S., Lim, S. F., Wang, T., Chung, B. Y. F., Jiat Teo, J., Chuan, K. H., Soon, A. S. C., Goh, K. S., & Song, Z. (2007) · Metabolic Engineering · doi:10.1016/j.ymben.2007.06.001 · Cited by 30
Metadata
- Authors
- Mittl, P. R. E., Di Marco, S., Krebs, J. F., Bai, X., Karanewsky, D. S., Priestle, J. P., Tomaselli, K. J., & Grütter, M. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-03
- Volume
- 272
- Issue
- 10
- Pages
- 6539-6547
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2154571107
- Cited by
- 250
- References
- 0
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.